EQRx Appoints Jami Rubin as Chief Financial Officer

EQRx appoints Jami Rubin as Chief Financial Officer, effective April 5. Jami has spent more than 25 years as an equity analyst working at companies including PJT Partners and Goldman Sachs. At Goldman Sachs, Jami ranked as a top pharmaceutical industry analyst. She is known for her advocacy for change in the industry, as well as her instrumental role in significant corporate transactions with leading pharmaceutical companies, including Pfizer, Abbott, AbbVie, Eli Lilly, and Company and Mylan.
 
EQRx is a privately held pharmaceutical company based in Cambridge, Massachusetts whose mission is remaking medicine. It has approximately 200 employees and was founded in 2019.